Jean E Mccormick

Array ( [id] => 5716169 [patent_doc_number] => 20060079532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Use of tetramethylpyrazine in the treatment of brain tumor' [patent_app_type] => utility [patent_app_number] => 10/961840 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2225 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079532.pdf [firstpage_image] =>[orig_patent_app_number] => 10961840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6939822 [patent_doc_number] => 20050113385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Method of treatment' [patent_app_type] => utility [patent_app_number] => 10/955838 [patent_app_country] => US [patent_app_date] => 2004-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4251 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113385.pdf [firstpage_image] =>[orig_patent_app_number] => 10955838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7435612 [patent_doc_number] => 20040266809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Method of treating multiple myeloma' [patent_app_type] => new [patent_app_number] => 10/847847 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1894 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266809.pdf [firstpage_image] =>[orig_patent_app_number] => 10847847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265114 [patent_doc_number] => 20040242650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Extended dosing regimen' [patent_app_type] => new [patent_app_number] => 10/842667 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4320 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242650.pdf [firstpage_image] =>[orig_patent_app_number] => 10842667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7465879 [patent_doc_number] => 20040198638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Water soluble paclitaxel derivatives' [patent_app_type] => new [patent_app_number] => 10/826302 [patent_app_country] => US [patent_app_date] => 2004-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 24222 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198638.pdf [firstpage_image] =>[orig_patent_app_number] => 10826302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 707849 [patent_doc_number] => 07060674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-13 [patent_title] => 'Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis' [patent_app_type] => utility [patent_app_number] => 10/819714 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11379 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060674.pdf [firstpage_image] =>[orig_patent_app_number] => 10819714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7427396 [patent_doc_number] => 20040229881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Methods of use of antimicrobial compounds against pathogenic mycoplasma bacteria' [patent_app_type] => new [patent_app_number] => 10/815984 [patent_app_country] => US [patent_app_date] => 2004-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1984 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229881.pdf [firstpage_image] =>[orig_patent_app_number] => 10815984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7311089 [patent_doc_number] => 20040143105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Purified heat shock protein complexes' [patent_app_type] => new [patent_app_number] => 10/754818 [patent_app_country] => US [patent_app_date] => 2004-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2326 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20040143105.pdf [firstpage_image] =>[orig_patent_app_number] => 10754818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7307303 [patent_doc_number] => 20040141924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Treatment of asthma with MEK inhibitors' [patent_app_type] => new [patent_app_number] => 10/753170 [patent_app_country] => US [patent_app_date] => 2004-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21480 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20040141924.pdf [firstpage_image] =>[orig_patent_app_number] => 10753170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 668544 [patent_doc_number] => 07094785 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-22 [patent_title] => 'Method of treating polycythemia vera' [patent_app_type] => utility [patent_app_number] => 10/739577 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4758 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094785.pdf [firstpage_image] =>[orig_patent_app_number] => 10739577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7475110 [patent_doc_number] => 20040097579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Taxane formulations' [patent_app_type] => new [patent_app_number] => 10/680649 [patent_app_country] => US [patent_app_date] => 2003-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80007 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097579.pdf [firstpage_image] =>[orig_patent_app_number] => 10680649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281392 [patent_doc_number] => 20040063769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders' [patent_app_type] => new [patent_app_number] => 10/677664 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10324 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063769.pdf [firstpage_image] =>[orig_patent_app_number] => 10677664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7411447 [patent_doc_number] => 20040106605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Synergistic methods and compositions for treating cancer' [patent_app_type] => new [patent_app_number] => 10/676214 [patent_app_country] => US [patent_app_date] => 2003-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9429 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106605.pdf [firstpage_image] =>[orig_patent_app_number] => 10676214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7412203 [patent_doc_number] => 20040106673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Compositions and methods for inhibiting proliferation in human prostate cancer cells' [patent_app_type] => new [patent_app_number] => 10/657685 [patent_app_country] => US [patent_app_date] => 2003-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5692 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106673.pdf [firstpage_image] =>[orig_patent_app_number] => 10657685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 737753 [patent_doc_number] => 07034058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-25 [patent_title] => 'Anti-tumor pharmaceutical composition comprising N-vanillyl fatty acid amide' [patent_app_type] => utility [patent_app_number] => 10/634641 [patent_app_country] => US [patent_app_date] => 2003-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5038 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/034/07034058.pdf [firstpage_image] =>[orig_patent_app_number] => 10634641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7387889 [patent_doc_number] => 20040029972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Combination treatment for depression' [patent_app_type] => new [patent_app_number] => 10/633847 [patent_app_country] => US [patent_app_date] => 2003-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9118 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029972.pdf [firstpage_image] =>[orig_patent_app_number] => 10633847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 711164 [patent_doc_number] => 07056929 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Benzo[b]pyrano[3,2-h]acridin-7-one compounds' [patent_app_type] => utility [patent_app_number] => 10/627463 [patent_app_country] => US [patent_app_date] => 2003-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11094 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056929.pdf [firstpage_image] =>[orig_patent_app_number] => 10627463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7459865 [patent_doc_number] => 20040052761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Localized delivery system for cancer drugs, phenstatin, using N-isopropylacrylamide' [patent_app_type] => new [patent_app_number] => 10/624294 [patent_app_country] => US [patent_app_date] => 2003-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3951 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20040052761.pdf [firstpage_image] =>[orig_patent_app_number] => 10624294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468827 [patent_doc_number] => 20040053998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Lipoxin analogs as novel inhibitors of angiogenesis' [patent_app_type] => new [patent_app_number] => 10/615361 [patent_app_country] => US [patent_app_date] => 2003-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22106 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053998.pdf [firstpage_image] =>[orig_patent_app_number] => 10615361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7362006 [patent_doc_number] => 20040014736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Stabililzed haloalkynyl microbicide compositions' [patent_app_type] => new [patent_app_number] => 10/602992 [patent_app_country] => US [patent_app_date] => 2003-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3423 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014736.pdf [firstpage_image] =>[orig_patent_app_number] => 10602992 [rel_patent_id] =>[rel_patent_doc_number] =>)